ISSN 3080-8022(Print)
ISSN 3080-8030(Online)
Past Views
Copyright

ISSN 3080-8022(Print)
ISSN 3080-8030(Online)
CODEN:SOABCV
International Standard Serial Identifier ·Globally Unique Identifier
Assigning Agency: Chemical Abstracts Service(CAS)
Distributed by:China International Book Trading Corporation(CIBTC)
Import Registration Number:G015Z112

Editorial Board
Editor-in-chief
Wen-tao Zheng 
Editor-in-Chief of Health Sciences
Professor Kai-Bin Huang/China
Deputy Editor-in-Chief
Xiao-Ming Li/72nd Group Army Hospital,People’s Liberation Army of China
Min Liu/Affiliated Hospital of Gansu University of Chinese Medicine,China
Xia-Bing Chen/China,Bishan Chen/China,Miao-Na Li/China,Sheng-Mei Ye/China,Yi-li Zhang/China,Xiao-Min Zhao/China,Dawen Peng/China,Jie-Ping Xu/China,Suleman Khan/UK,Saraju P.Mohanty/USA,Gautam Srivastava/Canada
(The above rankings are not in order)

Editorial Board Member
Shu-Bin LiuPhD/Gansu Provincial Hospital of Traditional Chinese Medicine,China
Yu-Wei Zhang/Chongqing University,China

Assistant to the Editorial Board
Xiao-Jing Li/China
Journal Homepage
Online Subm.
Join Us
Index / Retrieve / Archive
DOI
Index Copernicus International(Poland)
EuroPub Publishing Academic Literature Database (United Kingdom)
Academia(USA)
ResearchGate(RG) (Germany)
Yangtze River Database(China)
Open Access Library(OALib)(America)
ASCI(Asian Science Citation Index)
Vanderbilt University Medical Center(America)
ESJI Eurasian Science Journal Index(Kazakhstan)
Kind Congress
Research Bible(Japan)
Sci Online
Baidu Baike(China)
Baidu Scholar(China)
Google Scholar(America)
Editing and Publishing:
Quest Press Limited
Address:
Unit D, 7th Floor, No. 19, Rua de Pa̍k-chiông Vai, Macau
Telephone:
+853 6881 9699
Email:
QuestPress@hotmail.com
Web site:
https://sci.scionline2025.com


  Home Page -> Previous Views -> 2025
《Sci Online》( ISSN 3080-8022、EISSN 3080-8030 ) Publisher:Quest Press Release Date:2025/10/9
10.12479/questpress-scionline.20250101 Open Access Downloaded 4 Viewed 117

 

Sirt1 Runx2 Signaling Pathway Promotes Healing of Tibial Fracture in Rats

You Lyu   Li Fuli   Liu Guiguang
Department of Orthopaedics, Beijing Beiya Orthopaedics Hospital, Beijing 102445, China
Abstract : Objective: To investigate the effects of Sirtuin-1 (Sirt1)/Runt-related transcription factor 2 (Runx2) signaling pathway on the healing of tibial fracture in rats. Methods: Rat models of tibial fracture were established and hen divide d into fracture group (Fra group) and resveratrol treatment group (RES group). Next, the healing of fracture was exami ned by X-ray inspection. Bone marrow mesenchymal stem cells (BMSCs) were isolated from rats and cultured in vitro. Results: Rat models of tibial fracture were successfully established, and BMSCs were isolated and cultured.RES pro moted the healing of fracture in rats and the gene expressions of Sirt1 and Runx2 at fracture ends and in osteobla sts induced in vitro. According to alizarin red staining assay, RES facilitated the osteogenic differentiation of BMSCs , while EX-527 inhibited their osteogenic differentiation. QRT-PCR results revealed that the messenger ribonuc leic acid (mRNA) expressions of Sirt1 and Runx2 at tibial fractures at 24 h after fracture were significantly higher than th ose in sham group, and they were the highest in RES group. In addition, the mRNA expression levels of Sirt1 and Runx 2 were overtly higher in induction group and RES co-induction group than those in control group, whereas the indu ction with EX 527 evidently inhibited the mRNA expressions of Sirt1 and Runx2 at 2 w and 3 w. At 3 w after oste ogenic induction of BMSCs, both induction group and RES co-induction group had significantly increased protein exp ression levels of Sirt1 and Runx2. Conclusions: The Sirt1/Runx2 signaling pathway facilitates the healing of tibial fra cture in rats.
Keywords BMSCs;Sirt1/Runx2 signaling pathway;rats;tibial fracture
Document Retrieval Certificate / Proof of Publication Indexing
Author Contribution Statement / Certificate of Authorship Contribution
Peer Review Report / Peer Review Comments
Conflict of Interest
The author declares no conflict of interest.
Copyright Statement
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.
 
  Peer Review Editorial Services Research Ethics Policy Contributorship & Authorship About Quest Press / Macau Sino Int. Med. Press
  Global Indexing Copyright Licensing Data Sharing Policy Appeal/Correction/Retraction
  Online Submission To the Librarian Open Access Statement Misconduct Handling Policy
  Content Licensing Guidelines for Reviewers Quality Control Mechanism Academic Misconduct Screening Policy
  Advertising Policy Article Processing Charge (APC) Publication Ethics Policy Call for Editorial Board Members/Associate Editors/Peer Reviewers/Editors-in-Chief